nu2058 has been researched along with Prostatic Neoplasms in 1 studies
NU2058: structure in first source
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rigas, AC | 1 |
| Robson, CN | 1 |
| Curtin, NJ | 1 |
1 other study available for nu2058 and Prostatic Neoplasms
| Article | Year |
|---|---|
Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer.
Topics: Androgens; Anilides; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-D | 2007 |